Register Now
Youtube Linkedin Facebook

DxPx Startup City

Book your Booth now!

Our Startup City offers startups and growth companies the possibility to showcase their company. in the heart of the ADLM!

A great way to present your company to investors and partners.

We offer a limited number of exhibition booths directly in the partnering area and main  reception area.

dxpx-impressions-35

Startups: Exhibition opportunity in the heart of ADLM

  • The Startup City Area is accessible to ALL ADLM Participants - not just the DxPx audience!
  • Full-service package: including branded booth and electricity at no additional cost.
  • Gain visibility on site and feature your technology and products for investors from around the world.
  • Benefit from on- and off-line marketing of your participation (e.g. linkedin, interview, website).
  • Up to 24 spots; only 3 left!

Due to high demand, we operate on a first come, first served basis. Act quickly to:

Startup City Booths: SOLD OUT!
Startup tickets still available.
editable-for-web-DxPx-US-Floorplan-july-2023

Exhibitors from past events:

sponsor lino biotech

Life Science Tools

Label-free biosensoring directly from crude samples

lino Biotech is the world´s only provider of Focal Molography – an entirely new method for measuring molecular interactions in living cells or crude biological samples. The broadly patented technology offers label-free detection assays while eliminating signal disturbances due to temperature changes or non-specific binding.

Dr. Mirko Stange
Mirko Stange, CEO
nostics

Life Science Tools

Accessible technology, global impact

Our platform will bring instant diagnostics to every corner of the world. It will not only be able to improve the lives of millions of people, but also create a global monitoring system to provide insight into the spread of infectious diseases, generate valuable data, and act as an early warning system for the world.
Eva Rennen
Eva Rennen,
Co-Founder & COO

Download exhibitor information.

Benefits

Gain visibility among investors

Effective marketing of your companies USPs and investment opportunity. Positioned in the main lobby and partnering area, our booth help you to promote your message.

Your hub for meetings

In dependent of your one-to-one meeting itinerary, you have a personal hub to meet investors and partners at the booth.
exhibition booth

Marketing at the best

Use your booth to attract partners who you may have missed in the partnering and share information material of you company.

Get your tickets now!

To the ticket shop
DxPx US 2023

Ratio % of
DxPx Participants:

Private equity & growth company partnering breakfast

At DxPx US we host a dedicated breakfast to feature a limited number of pre-selected growth companies to private equity funds. We strive for a one-to-one ratio of executives and investors. Number of participants is limited and participating growth companies are selected by leading investors and business experts.

Private equity & growth company partnering breakfast
Private equity & growth company partnering breakfast

Benefits from this partnering breakfast:

  • Free participation if selected
  • Capped at maximum of 15 selected growth companies
  • 1 hour breakfast networking with at least 15 private equities
  • Follow up discussions possible in private meeting areas during regular DxPx hours or evening reception
  • Good coffee & more
Contact us for more information.

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience